Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 07 Jul 2023
Data from a recent study that was published in NEJM Evidence suggests that short-term ADT, when used in a personalized manner in men who are primarily intermediate-risk, has some promise.
Read Full NewsNot all adrenal incidentalomas need the same workup. The Curbsiders break down when to worry, what to test, and why MACS may be behind your patient's hard-to-control metabolic disease.
Dr Maurie Markman examines new registry data on ovarian cancer diagnostic timing, showing how disease biology can complicate the link between early detection and survival.
Dr Andrea Chadwick describes how the shift from tender points to symptom-based criteria has improved fibromyalgia diagnosis, understanding, and patient-centered care.
Dr Anne Peters discusses the expanding use of continuous glucose monitoring in people with diabetes.
Before you freeze a skin lesion, ask yourself whether you really know what it is. Here are four signs you should biopsy instead of freeze.
EyePoint said its experimental drug missed the main goal in a late-stage trial as a few patients lost vision from causes unrelated to the targeted disease, sending its...
The FDA has approved a radioactive agent for use in brain scans to help assess patients for Alzheimer's disease.
1.
Through Consolidation Durvalumab, Limited-Stage SCLC Receives a New Standard of Care.
2.
Breast density changes over time are associated with an increased risk of cancer.
3.
New research demonstrates a method for screening people at high risk for pancreatic cancer.
4.
Study sheds light on challenges for women of color after breast cancer surgery
5.
Optimizing Sequencing of BCMA-Directed Therapies in Myeloma
1.
Unlocking the Potential of Plinabulin: A New Frontier in Cancer Treatment
2.
Beyond the Blinders: A Review of Targeted Therapeutic Strategies for Triple-Negative Breast Cancer in 2025
3.
The Evolving Arsenal: A 2025 Review of Antibody-Drug Conjugates and the Future of Precision Oncology
4.
Women's Health Through Understanding Hematologic Adaptation Across Menstrual and Reproductive Stages
5.
Emerging Methods in Hematology in Clinical Decision-Making
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
1.
Efficient Management of First line ALK-rearranged NSCLC - Part III
2.
Rates of CR/CRi and MRD Negativity in Iontuzumab-Treated Patients
3.
Treatment Paradigm for Patients with R/R Adult B-cell ALL- Expert Discussions
4.
Early Cancer Detection Saves Lives
5.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge